585 related articles for article (PubMed ID: 11804649)
1. Mouse models of Huntington's disease.
Menalled LB; Chesselet MF
Trends Pharmacol Sci; 2002 Jan; 23(1):32-9. PubMed ID: 11804649
[TBL] [Abstract][Full Text] [Related]
2. The use of transgenic and knock-in mice to study Huntington's disease.
Hickey MA; Chesselet MF
Cytogenet Genome Res; 2003; 100(1-4):276-86. PubMed ID: 14526189
[TBL] [Abstract][Full Text] [Related]
3. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.
Wang LH; Qin ZH
Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735
[TBL] [Abstract][Full Text] [Related]
4. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
6. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
7. Genetics and neuropathology of Huntington's disease.
Reiner A; Dragatsis I; Dietrich P
Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
[TBL] [Abstract][Full Text] [Related]
8. Lessons from animal models of Huntington's disease.
Rubinsztein DC
Trends Genet; 2002 Apr; 18(4):202-9. PubMed ID: 11932021
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
[TBL] [Abstract][Full Text] [Related]
10. Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice.
Gil-Mohapel JM
CNS Neurosci Ther; 2012 Jan; 18(1):77-86. PubMed ID: 21501423
[TBL] [Abstract][Full Text] [Related]
11. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.
Sathasivam K; Woodman B; Mahal A; Bertaux F; Wanker EE; Shima DT; Bates GP
Hum Mol Genet; 2001 Oct; 10(21):2425-35. PubMed ID: 11689489
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ
Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of neuronal cell death in Huntington's disease.
Sawa A; Tomoda T; Bae BI
Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190
[TBL] [Abstract][Full Text] [Related]
14. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.
Möncke-Buchner E; Reich S; Mücke M; Reuter M; Messer W; Wanker EE; Krüger DH
Nucleic Acids Res; 2002 Aug; 30(16):e83. PubMed ID: 12177311
[TBL] [Abstract][Full Text] [Related]
15. How does the Huntington's disease mutation damage cells?
Rubinsztein DC
Sci Aging Knowledge Environ; 2003 Sep; 2003(37):PE26. PubMed ID: 13679594
[TBL] [Abstract][Full Text] [Related]
16. Experimental models of HD and reflection on therapeutic strategies.
Kim J; Bordiuk OL; Ferrante RJ
Int Rev Neurobiol; 2011; 98():419-81. PubMed ID: 21907096
[TBL] [Abstract][Full Text] [Related]
17. Huntington's disease.
Roze E; Bonnet C; Betuing S; Caboche J
Adv Exp Med Biol; 2010; 685():45-63. PubMed ID: 20687494
[TBL] [Abstract][Full Text] [Related]
18. Transgenic rat model of Huntington's disease.
von Hörsten S; Schmitt I; Nguyen HP; Holzmann C; Schmidt T; Walther T; Bader M; Pabst R; Kobbe P; Krotova J; Stiller D; Kask A; Vaarmann A; Rathke-Hartlieb S; Schulz JB; Grasshoff U; Bauer I; Vieira-Saecker AM; Paul M; Jones L; Lindenberg KS; Landwehrmeyer B; Bauer A; Li XJ; Riess O
Hum Mol Genet; 2003 Mar; 12(6):617-24. PubMed ID: 12620967
[TBL] [Abstract][Full Text] [Related]
19. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanisms in Huntington's disease.
Jones L; Hughes A
Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
